Globally, lung cancer has the highest mortality rate [@bib0005]. By the time lung cancer is clinically symptomatic or can be detected by chest X-ray, it is already at a high stage and is not curable [@bib0010], [@bib0015]. In China, due to the concern of the relationship between air pollution and lung cancer and in the hope to catch the disease at an early stage, LDCT screening of "high risk" individuals is gaining in popularity [@bib0020]. However, the pathologic characteristics and particularly, the rate of malignancy in CT detected sub-centimeter lung nodules is not clear [@bib0025], [@bib0030], [@bib0035]. Analysis of surgically resected specimens in this patient group may provide insights into the demographic characteristics of these sub-centimeter nodules, the cost effectiveness of such screening and, importantly, recommendations on the subsequent clinical management.

1. Material & methods {#sec0005}
=====================

From July 2013 to March 2015, 44 asymptomatic patients with 46 sub-centimeter lung nodules (two patients each had 2 nodules) that were detected by LDCT screening and subsequently underwent CT-guided hook-needle localization and video-assisted thoracoscopic surgery (VATS) were retrospectively selected from the pathology database of Northern Campus of Shanghai No. 9 People's Hospital. The patient's demographics and the radiologic and pathologic characteristics of these nodules were collected from the records and included gender, age, nodule location, size, shape, density, relation to major vessels, relation to visceral pleura, history of smoking and the major reasons for surgery. CT scanning Brilliance-64, MX-8000 IDT CT scanner (Philips Medical Systems, Cleveland, OH) was acquired at the end of inspiration and performed from the thoracic inlet to the upper portion of the kidneys. The scanning parameters were as follows: 120 kVp, 40--60 mAs, and a pitch of 0.875. Thin-section CT images were reconstructed into 0.675 mm section thicknesses using high-frequency algorithms and displayed at standard window setting (width, 1600 HU; level,−400 HU). In some cases, follow-up CT scans were performed at 3-, 6- and 12- months. All CT images were anonymized and reviewed by two radiologists. The image analyses were based on the 2013 recommendations by the Fleischner Society [@bib0035], [@bib0040]. The following thin-section reconstruction CT measurements were recorded: lesion size, distance to pleura, pulmonary location, shape on transverse and reconstruction imaging (round or oval, polygonal, irregular), margin (smooth, lobulated, spiculated), border (well-defined, ill-defined), density(solid opacity, mixed ground-glass, pure ground-glass), relation to vascular structure (pass through, convergence, unrelated). Lesion size was measured based on the average of long and short axial dimensions. The distance to pleura was defined between the center of the lesion and visceral pleural. Patients all underwent CT-guided hook-needle localization of the suspected nodules (PAJUNK, Mammography, Germany, 275S090120S 20G × 120 mm) before VATS. At the time of wedge resection, frozen sections performed for initial diagnosis. All specimens were then submitted for permanent section with formalin fixation and paraffin embedding for final diagnosis. All diagnoses were confirmed by 2 pathologists ([Fig. 1](#fig0005){ref-type="fig"}, [Fig. 2](#fig0010){ref-type="fig"}, [Fig. 3](#fig0015){ref-type="fig"}, [Fig. 4](#fig0020){ref-type="fig"} ).

Statistical analysis was performed using SPSS version 19.0. The independent sample *t* test was used for continuous variables, such as age, lesion size and distance to pleura. The chi-square test was used for categorical data to compare CT image findings. A value of P \< 0.05 was considered statistically significant. Due to the subjectivity of the differential diagnostic criteria, nodules previously diagnosed as AAH and AIS were combined into one group for statistical analysis. There were 29 nodules in this group with, only two \<5 mm; based on current WHO criteria, the majority of these nodules are qualify for the diagnosis of AIS .

2. Results {#sec0010}
==========

As shown in [Table 1](#tbl0005){ref-type="table"}, [Table 2](#tbl0010){ref-type="table"}, Patients were selected for surgery due to the following reasons: growth in size during the 3--12 month follow up periods (5 cases); family history of lung cancer (2 cases); personal history of cancers of other sites (11 cases); previous chronic lung disease, including chronic bronchitis and COPD (8 cases); smoking (1 case) and for many cases, personal anxiety about the CT detected lung nodules played a significant role (19 cases). All resected nodules were also classified by radiologists to be suspicious based on their experience. Of the 44 patients, 33 were women and 11 were men, age range 43--76 years (56.75 ± 8.44 SD). Of the 46 nodules (two patients had 2 nodules), pathological diagnoses were: invasive adenocarcinoma (ACa) in 4 (8.7%); adenocarcinoma in situ (AIS) and atypical adenomatous hyperplasia (AAH) in 29 (63%); benign fibrosis/fibrotic scar with inflammation or calcification in 12 (26.1%); intrapulmonary benign lymph node in 1 (2.2%). Of the ACa, AIS and AAH groups (a total of 31 patients), 77% were women (24 vs. 7). Interestingly, only one out of 31 patients in this group was a smoker.

Amongst all characteristics, significant statistical differences were found between the ACa/AIS/AAH nodule group and benign nodule group when the following radiological features were considered: reconstructed nodule shape (P = 0.011), margin (P = 0.003) and ground glass opacity density (P = 0.000). The patient's age, the axial morphology of the lesion, relationship to major vessels or visceral pleura and location of the nodule within the lung parenchyma were not predictive of the pathologic diagnosis. Only one of the 31 patients with a cancer or pre-cancer nodules was a smoker. All 46 nodules were equal or less than 10 mm, mean ± SD is 7.81 ± 1.81 mm. Respectively, mean size was, adenocarcinoma, 9.57 mm, AIS, 8.16 mm and AAH, 4.15 mm, although there was no statistical difference in size among all groups, cancer and pre-cancer nodules put together as one group tended to be larger than benign fibrotic scars (P = 0.039). The average distance between the nodules to the pleura was 9.18 mm, and there was no statistical difference in the distance to the pleura.

3. Discussion {#sec0015}
=============

This is a retrospective study based on a single hospital pathology practice. We focused on surgically resected lung nodules that were detected by LDCT screening of asymptomatic individuals. Although the study is limited by the relatively small sample size and single centre practice, there were some interesting findings. First, among the 31 patients with cancer and pre-cancer conditions (i.e. AAH, AIS and ACa), 24 were female (77%) and 7 were men. This is in contrast to the prevailing paradigm that lung cancer is a male predominant disease [@bib0005]. It is possible that the pre-cancerous/pre-invasive (AAH and AIS) nodules grow very slowly and are therefore more likely to be included in this group of sub-centimeter incidental nodules. It is also possible that female patients were more likely to request removal of their incidental lung nodules due to anxiety. Genetic differences from the western population, on which much of the present studies are based, may explain our findings [@bib0045]. It is known that EGFR mutations in lung cancer are more common in women, in patients who have never smoked tobacco and in East Asians [@bib0050], and there is some evidence that EGFR mutations are over-represented in more low-grade lung cancers [@bib0055]. However, we do not have this data for our group. Another interesting finding was that of the 31 patients with cancer and pre-cancer nodules, only one (a woman), was a smoker. The inclusion criteria "at least a 30 pack-year smoking history who smoke or quit smoking \<15 years ago" is used in most LDCT screening programs [@bib0060], [@bib0065], [@bib0070], which are based on data generated from North America or European population. Therefore our findings raise an important question -- will screening programs based on these inclusion criteria exclude a significant proportion of the population that may benefit from screening, at least in the Chinese population. Most published studies indicate that the malignancy ratio in LDCT detected lung nodules is very small with a false positive rate of approximately 96% [@bib0060], [@bib0065], [@bib0070], [@bib0075], [@bib0080], but these papers are based on Western populations and we do not know how applicable this is in our population. Currently, there are no recommendations or guidelines for LDCT lung cancer screening in China. Due to the concerns that air pollution is a risk factor for lung cancer, many companies include LDCT screening as part of an employee's annual physical exam, as is the case for the patients in our study. The patients were selected for surgery based on a combination of the experience of the radiologists and surgeons experiences and the individual patient's anxiety level. It is clear that more studies investigating different screening inclusion criteria and standardized "lung nodule management algorithms" are necessary to determine the optimal practice in the Chinese population. The newly published NELSON data concluded that measurement of nodule volumetry may provide better prediction on the risk of incidental lung nodules [@bib0085]. Our study also showed that reconstructed nodule shape, lobulated margin and ground glass density on 0.67 mm section thickness scans using high-frequency algorithms displayed at standard window setting may help to identify high risk nodules.

4. Conclusion {#sec0020}
=============

In conclusion, although this was a relatively small study from a single center, our findings suggest that the current published inclusion criteria for LDCT screening for lung cancer in China might exclude a significant number of patients who are at risk. Further studies are required in this area.
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![63 year old female. A. Right lower lobe opacity; B. Reconstructed image of 0.67 mm section thickness using high-frequency algorithms and displayed at standard window setting showing solid opacity. C, D：Reconstructed crown and sagittal images showing irregular border and micro vasculature passing though. E & F：CT-guided hookwire localizatio before VATS. G: Histology HE × 400 showing AAH.](gr1){#fig0005}

![46 year old female. A. Right lower lobe opacity; B, C. Reconstructed image of 0.67 mm section thickness using high-frequency algorithms and displayed at standard window setting showing solid opacity. D. Post CT-guided hookwire localizatio VATS histology diagnosis is AIS (HE × 400).](gr2){#fig0010}

![63 year old man. CT screen show left lower lobe lung irregular opacity. B. one year later, follow up CT show the lesion is increasing in size and density. The lesion also has speculated shape, ill-defined boarder and uneven density. C. wedge resection and subsequent lobectomy show well differentiated invasive adenocarcinoma (H&E × 400).](gr3){#fig0015}

![75 year old man with history of COPD. A. Screening CT show left lower lobe dense opacity. B & C. Reconstructed crown and saggital images show irregular speculated lesion shape but defined boarders with surrounding lung parenchyma. D. CT-guided hookwire VATS wedge resection show fibrous scare)H&E × 400).](gr4){#fig0020}

###### 

Case summary.

Table 1

  Final pathology diagnosis                  Gender      Age   Location   Reason of Operation   Size (mm)      Distance to pleura   Transverse Shape   Reconstructed Shape   Margin       Border       Density      Vascularity                     
  --------------------------- -------------- ----------- ----- ---------- --------------------- -------------- -------------------- ------------------ --------------------- ------------ ------------ ------------ -------------- ---------------- --------------
  AAH &                       AIS            1                 f          48                    Right Upper    Anxiety              9.90               18.00                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Unrelated
                                             2                 f          46                    Right Lower    Anxiety              3.50               5.30                  Round/oval   Polygonal    Lobular      Well-defined   Part-solid GGO   Pass through
                                             3                 f          52                    Right Upper    Enlarged             10.00              7.30                  Round/oval   Irregular    Lobular      Ill-defined    Part-solid GGO   Convergence
                                             4                 f          68                    Left Upper     Thyroid CA           9.20               10.60                 Irregular    Polygonal    Speculated   Well-defined   Part-solid GGO   Convergence
                                             5                 m          51                    Right Upper    Hx of Lung disease   10.00              20.90                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Pass through
                                             6                 f          49                    Left Lower     Thyroid CA           7.60               6.30                  Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Unrelated
                                             7                 f          55                    Right Upper    Anxiety              7.30               11.40                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Pass through
                                             8                 f          53                    Right Lower    Smoking              9.00               5.50                  Round/oval   Round/oval   Lobular      Well-defined   Part-solid GGO   Pass through
                                             9                 f          53                    Left Lower     Anxiety              6.30               5.90                  Polygonal    Polygonal    Lobular      Well-defined   Part-solid GGO   Pass through
                                             10                f          70                    Left Upper     Breast CA            8.60               12.30                 Polygonal    Polygonal    Lobular      Well-defined   Pure GGOs        Convergence
                                             11                m          68                    Right Upper    Anxiety              8.90               6.40                  Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Pass through
                                             12                .          .                     Right Upper                         5.00               23.90                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Unrelated
                                             13                f          54                    Right Upper    Family Hx lung CA    8.30               26.50                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Pass through
                                             14                m          51                    Left Upper     Family Hx lung CA    9.90               12.30                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Convergence
                                             15                f          48                    Right Upper    Anxiety              7.70               17.20                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Convergence
                                             16                f          52                    Right Upper    Anxiety              8.80               4.20                  Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Convergence
                                             17                f          49                    Left Upper     Anxiety              7.00               19.50                 Polygonal    Polygonal    Lobular      Well-defined   Pure GGOs        Unrelated
                                             18                f          67                    Left Lower     Hx of Lung disease   7.00               5.80                  Irregular    Irregular    Lobular      Well-defined   Pure GGOs        Pass through
                                             19                f          75                    Left Lower     Hx of Lung disease   9.20               4.40                  Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Convergence
                                             20                f          52                    Right Lower    Hx lung CA           9.40               41.80                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Unrelated
                                             21                m          64                    Left Upper     Enlarged             10.00              28.90                 Polygonal    Polygonal    Lobular      Well-defined   Part-solid GGO   Convergence
                                             22                f          51                    Left Upper     Anxiety              4.80               15.90                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Unrelated
                                             23                .          .                     Left Upper                          7.20               29.00                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Unrelated
                                             24                f          55                    Right Lower    Anxiety              5.10               7.20                  Polygonal    Polygonal    Lobular      Well-defined   Pure GGOs        Unrelated
                                             25                f          63                    Right Middle   Hx of Lung disease   5.40               9.70                  Round/oval   Round/oval   Lobular      Well-defined   Solid opacity    Unrelated
                                             26                f          54                    Left Lower     Anxiety              8.20               13.60                 Polygonal    Polygonal    Lobular      Well-defined   Pure GGOs        Pass through
                                             27                f          49                    Left Lower     Anxiety              9.30               14.00                 Polygonal    Irregular    Lobular      Well-defined   Pure GGOs        Convergence
                                             28                m          50                    Right Lower    Anxiety              7.70               16.50                 Round/oval   Round/oval   Lobular      Well-defined   Part-solid GGO   Convergence
                                             29                f          62                    Right Lower    Anxiety              8.50               23.00                 Irregular    Irregular    Lobular      Well-defined   Part-solid GGO   Convergence
                                             Total (N)   N     27         27                    29             27                   29                 29                    29           29           29           29             29               29
                                                                                                                                                                                                                                                    
                              Fib & ch inf   1                 f          53                    Right Lower    Hx of Lung disease   7.60               19.30                 Polygonal    Irregular    Lobular      Well-defined   Part-solid GGO   Convergence
                                             2                 f          47                    Right Lower    Hx of Ovarian CA     4.90               6.90                  Polygonal    Polygonal    Spiculated   Well-defined   Part-solid GGO   Convergence
                                             3                 f          51                    Right Lower    Hx of Lung disease   8.50               8.80                  Irregular    Irregular    Lobular      Well-defined   Solid opacity    Unrelated
                                             4                 m          56                    Left Lower     Hx of Lung disease   8.50               14.20                 Polygonal    Irregular    Spiculated   Well-defined   Solid opacity    Convergence
                                             5                 f          54                    Left Lower     Hx of Breast CA      8.30               9.20                  Polygonal    Irregular    Lobular      Well-defined   Solid opacity    Pass through
                                             6                 f          48                    Left Lower     Hx of Breast CA      5.50               3.50                  Polygonal    Polygonal    Lobular      Well-defined   Part-solid GGO   Convergence
                                             7                 f          71                    Right Upper    Hx lung CA           8.60               5.60                  Irregular    Irregular    Lobular      Ill-defined    Pure GGOs        Convergence
                                             8                 m          76                    Left Lower     Hx of Lung disease   6.80               9.90                  Round/oval   Round/oval   Lobular      Well-defined   Part-solid GGO   Pass through
                                             9                 m          65                    Left Upper     Anxiety              4.70               9.80                  Round/oval   Irregular    Lobular      Well-defined   Solid opacity    Unrelated
                                             10                f          43                    Right Middle   Hx of Breast CA      9.90               6.20                  Irregular    Irregular    Spiculated   Ill-defined    Part-solid GGO   Convergence
                                             11                f          67                    Right Upper    Enlarged             8.50               11.30                 Round/oval   Round/oval   Lobular      Well-defined   Solid opacity    Convergence
                                             Total (N)         11         11                    11             11                   11                 11                    11           11           11           11             11               11
                                                                                                                                                                                                                                                    
                              ACa            1                 f          56                    Right Upper    Anxiety              9.60               8.10                  Irregular    Irregular    Lobular      Well-defined   Part-solid GGO   Pass through
                                             2                 m          58                    Right Middle   Enlarged             10.00              14.10                 Polygonal    Polygonal    Spiculated   Well-defined   Part-solid GGO   Pass through
                                             3                 f          53                    Left Upper     Anxiety              8.70               24.30                 Round/oval   Round/oval   Lobular      Well-defined   Pure GGOs        Pass through
                                             4                 m          63                    Left Lower     Enlarged             10.00              3.00                  Polygonal    Polygonal    Spiculated   Well-defined   Part-solid GGO   Convergence
                                             Total (N)   N     4          4                     4              4                    4                  4                     4            4            4            4              4                4
                              Benign LN      1                 f          58                    Right Lower    Anxiety              5.60               7.30                  Round/oval   Round/oval   Lobular      Well-defined   Solid opacity    Unrelated
                                             Total (N)   N     1          1                     1              1                    1                  1                     1            1            1            1              1                1
                              Cal.           1                 m          69                    Right Upper    Anxiety              5.10               7.00                  Polygonal    Irregular    Lobular      Well-defined   Part-solid GGO   Unrelated
                                             Total (N)   N     1          1                     1              1                    1                  1                     1            1            1            1              1                1
                              Total          N                 44         44                    46             46                   46                 46                    46           46           46           46             46               46

Abbreviations: CA: carcinoma. ACa: invasive adenocarcinoma. AIS: adenocarcinoma in situ. AAH: atypical adenomatous hyperplasia. LN: lymph node. Cal: calcification. Abs: abscess. Fib & Ch Inf.: fibrosis & chronic inflammation. Hx of: history of.

###### 

Comparison of LDCT image characteristics between cancer/pre-cancer lesions (ACa, AIS, AAH) and Other benign lesions (Fib., LN, Cal).

Table 2

                         Others (13)   ACa/AIS/AAH (33)   P value
  ---------------------- ------------- ------------------ ---------
  Shape Transverse                                        
   Irregular             3             4                  0.181
                         23.1%         12.1%              
   Polygonal             6             9                  
                         46.2%         27.3%              
   Round/oval            4             20                 
                         30.8%         60.6%              
                                                          
  Shape Reconstructed                                     
   Irregular             28            5                  0.011
                         61.5%         15.2%              
   Polygonal             2             10                 
                         23.1%         30.3%              
   Round/oval            3             18                 
                         23.1%         54.5%              
                                                          
  Margin                                                  
   Smooth                7             5                  
                         53.8%         15.2%              0.003
   Lobular               3             25                 
                         23.1%         75.8%              
   Speculated            3             3                  
                         23.1%         9.1%               
                                                          
  Border                                                  
   Ill-defined           2             1                  0.188
                         15.4%.        3.0%               
   Well-defined          11            32                 
                         84.6%         97.0%              
                                                          
  Density                                                 
   Part-solid GGO        6             11                 
                         46.2%         33.3%              0.000
   Solid opacity         6             1                  
                         46.2%         3.0%               
   Pure GGOs             1             21                 
                         7.7%          63.6%              
                                                          
  Surrounding vascular                                    
   Pass through          2             12                 0.385
                         15.4%         36.4%              
   Convergence           7             12                 
                         53.8%         36.4%              
   Unrelated             4             9                  
                         30.8%         27.3%              
                                                          
  Location                                                
   Left lower            4             7                  
                         30.8%         21.2%              0.640
   Left upper            1             8                  
                         7.7%          24.2%              
   Right middle          1             2                  
                         7.7%          6.1%               
   Right lower           4             6                  
                         30.8%         18.2               
   Right upper           3             10                 
                         23.1%         30.3%              

[^1]: XH and JZ contributed equally.
